Live News Categoriesequity

Orion Oyj (ORNBV.HE) News

Follow Orion Oyj (ORNBV.HE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ORNBV.HE Asset equity Sector Markets 90 days 1 Last 82.65 Updated Oct 06, 2026, 06:01 AM UTC Open live news feed Open ORNBV.HE chart & news

M Orion Pharma to commercialize Qilu's pembrolizumab biosimilar in Europe Orion Pharma has signed an agreement with Qilu Pharma Europe to distribute, market, and sell an intravenous pembrolizumab biosimilar across Europe. Qilu will supply the biosimilar and receive profit share, development, r EQUITY | Oct 06, 2026, 06:01 AM UTC